tiprankstipranks
MiMedx Group (MDXG)
NASDAQ:MDXG
US Market

MiMedx Group (MDXG) Technical Analysis

Compare
368 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
4Neutral
12Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
MiMedx Group’s (MDXG) Moving Averages Convergence Divergence (MACD) indicator is -0.23, suggesting MiMedx Group is a Buy.
MiMedx Group’s (MDXG) 20-Day exponential moving average is 8.43, while MiMedx Group’s (MDXG) share price is $7.85, making it a Sell.
MiMedx Group’s (MDXG) 50-Day exponential moving average is 8.56, while MiMedx Group’s (MDXG) share price is $7.85, making it a Sell.

MiMedx Group (MDXG) Pivot Points

Feb 22, 2025, 01:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.72
7.87
7.96
8.11
8.20
8.35
8.44
Fibonacci
7.87
7.96
8.01
8.11
8.20
8.25
8.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MiMedx Group (MDXG) Moving Averages

Feb 22, 2025, 01:23 AM
Period
Simple
Exponential
MA5
8.16Sell
8.09Sell
MA10
8.23Sell
8.23Sell
MA20
8.51Sell
8.43Sell
MA50
8.92Sell
8.56Sell
MA100
8.02Sell
8.23Sell
MA200
7.46Buy
7.77Buy
MiMedx Group’s (MDXG) 10-Day exponential moving average is 8.23, while MiMedx Group’s (MDXG) share price is $7.85, making it a Sell.
MiMedx Group’s (MDXG) 100-Day exponential moving average is 8.23, while MiMedx Group’s (MDXG) share price is $7.85, making it a Sell.
MiMedx Group’s (MDXG) stock price is $7.85 and MiMedx Group’s (MDXG) 50-day simple moving average is 8.92, creating a Sell signal.
MiMedx Group’s (MDXG) stock price is $7.85 and MiMedx Group’s (MDXG) 100-day simple moving average is 8.02, creating a Sell signal.
MiMedx Group’s (MDXG) stock price is $7.85 and MiMedx Group’s (MDXG) 200-day simple moving average is 7.46, creating a Buy signal.

MiMedx Group (MDXG) Technical Indicators

Feb 22, 2025, 01:23 AM
Name
Value
Implied Action
RSI (14)
30.42
Neutral
STOCH (9,6)
22.58
Neutral
STOCHRSI (14)
12.61
Buy
MACD (12,26)
-0.23
Buy
ADX (14)
21.12
Neutral
Williams %R
-96.58
Buy
CCI (14)
-153.37
Buy
ATR (14)
0.28
-
Ultimate Oscillator
36.14
Neutral
ROC
-11.90
Sell
MiMedx Group’s (MDXG) Relative Strength Index (RSI) is 30.42, creating a Neutral signal.
MiMedx Group’s (MDXG) Trend Strength Indicator (ADX) is 21.12, creating a Neutral signal.
MiMedx Group’s (MDXG) Commodity Channel Index (CCI) is -153.37, creating a Buy signal.
MiMedx Group’s (MDXG) Price Rate of Change (ROC) is -11.90, creating a Sell signal.

FAQ

Is MDXG a Buy, Hold, or Sell?
Based on MDXG’s technical indicators, MDXG is a Sell.
    What is MDXG’s RSI (14)?
    MDXG’s RSI (14) is 30.42, which suggests MDXG is a Neutral.
      What is MDXG’s MACD?
      MDXG’s MACD is -0.23, which suggests MDXG is a Buy.
        What is MDXG’s 5-day moving average?
        MDXG’s 5-day moving average is 8.16, which suggests MDXG is a Sell.
          What is MDXG’s 20-day moving average?
          MDXG 20-day moving average is 8.51, which suggests MDXG is a Sell.
            What is MDXG’s 50-day moving average?
            MDXG’s 50-day moving average is 8.92, which suggests MDXG is a Sell.
              What is MDXG’s 200-day moving average?
              MDXG’s 200-day moving average is 7.46, which suggests MDXG is a Buy.
                What is MDXG’s Williams % R (14)?
                MDXG’s Williams % R (14) is -96.58, which suggests MDXG is a Buy.
                  What is MDXG’s CCI (14)?
                  MDXG’s CCI (14) is -153.37, which suggests MDXG is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis